LINDA KEO: Open Payments
NPI 1881317592 · LOWELL, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,075 in 46 payments from 15 companies in 2025. Trend: 2023 $36 · 2024 $1,346 · 2025 $1,075
Food & beverage: $1,075
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $214 |
| Novo Nordisk Inc | 6 | $117 |
| AstraZeneca Pharmaceuticals LP | 4 | $96 |
| Amgen Inc. | 4 | $91 |
| Lilly USA, LLC | 4 | $89 |
| Exact Sciences Corporation | 4 | $86 |
| ABBVIE INC. | 4 | $81 |
| PFIZER INC. | 3 | $77 |
| Alexion Pharmaceuticals, Inc. | 2 | $59 |
| Agios Pharmaceuticals, Inc. | 2 | $56 |
Products named: Kerendia, EVENITY, JARDIANCE, PREVNAR 20, Ozempic, UBRELVY, STRENSIQ, PYRUKYND.
Industry payments across MA — which companies pay providers there.
